A good growth outlook is seen for Verve Therapeutics Inc (VERV) Stock by analysts
H.C. Wainwright raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 08, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Neutral, with a price target set at $21. The stock was initiated by Goldman, who disclosed in […]
Consensus Analyst Estimated Price Target of $31.22 for Verve Therapeutics Inc (NASDAQ:VERV) Stock
H.C. Wainwright raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 08, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Neutral, with a price target set at $21. The stock was initiated by Goldman, who disclosed in […]
The Verve Therapeutics Inc (VERV) Stock expansion path ahead
H.C. Wainwright raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 08, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Neutral, with a price target set at $21. The stock was initiated by Goldman, who disclosed in […]
Verve Therapeutics Inc (VERV) Stock deserves your attention
H.C. Wainwright raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on Apr-09-24, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Neutral, with a price target set at $21. The stock was initiated by Goldman, who disclosed in a research […]
The idea of catching Verve Therapeutics Inc (VERV) Stock might be a good one
Canaccord Genuity raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 13, 2023, according to finviz. The research report from Goldman has initiated the stock to Sell, with a price target set at $13. The stock was initiated by Credit Suisse, who disclosed in […]
Analyzing Verve Therapeutics Inc’s (VERV) Stock earnings per share and revenue
Canaccord Genuity raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 13, 2023, according to finviz. The research report from Goldman has initiated the stock to Sell, with a price target set at $13. The stock was initiated by Credit Suisse, who disclosed in […]
Risks and Returns of Verve Therapeutics Inc (VERV) Stock
Canaccord Genuity raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 13, 2023, according to finviz. The research report from Goldman has initiated the stock to Sell, with a price target set at $13. The stock was initiated by Credit Suisse, who disclosed in […]
Verve Therapeutics Inc (VERV) Stock is looking to regain its victory
Canaccord Genuity raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 13, 2023, according to finviz. The research report from Goldman has initiated the stock to Sell, with a price target set at $13. The stock was initiated by Credit Suisse, who disclosed in […]
Verve Therapeutics Inc (VERV) Stock is expected to generate profits in the near future
Canaccord Genuity raised the price target for the Verve Therapeutics Inc (NASDAQ:VERV) stock to “a Buy”. The rating was released on April 13, 2023, according to finviz. The research report from Goldman has initiated the stock to Sell, with a price target set at $13. The stock was initiated by Credit Suisse, who disclosed in […]
